238 related articles for article (PubMed ID: 27867003)
1. Prognostic Impact of Newly Proposed M Descriptors in TNM Classification of Non-Small Cell Lung Cancer.
Shin J; Keam B; Kim M; Park YS; Kim TM; Kim DW; Kim YW; Heo DS
J Thorac Oncol; 2017 Mar; 12(3):520-528. PubMed ID: 27867003
[TBL] [Abstract][Full Text] [Related]
2. M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.
Park H; Dahlberg SE; Lydon CA; Araki T; Hatabu H; Rabin MS; Johnson BE; Nishino M
Oncologist; 2019 Aug; 24(8):e749-e754. PubMed ID: 30696724
[TBL] [Abstract][Full Text] [Related]
3. Tumor, node and metastasis classification of lung cancer--M1a versus M1b--analysis of M descriptors and other prognostic factors.
Sánchez de Cos Escuín J; Abal Arca J; Melchor Íñiguez R; Miravet Sorribes L; Núñez Ares A; Hernández Hernández JR; García Arangüena L; Núñez Delgado M; Pavón Fernández MJ; Francisco Corral G; de Esteban Júlvez L; González Budiño MT; Abad Cavaco F; Ansótegui Barrera E; Andreo García F; Serra Mitjans M; Hernández Rodríguez H
Lung Cancer; 2014 May; 84(2):182-9. PubMed ID: 24629637
[TBL] [Abstract][Full Text] [Related]
4. Validation of prognostic impact of number of extrathoracic metastases according to the eighth TNM classification: a single-institution retrospective study in Japan.
Sakai K; Kuramoto J; Kojima A; Nishimura H; Kuwabara Y; Toda M; Kobayashi Y; Kikuchi S; Hirata Y; Mikami-Saito Y; Mikami S; Kyoyama H; Moriyama G; Gemma A; Uematsu K
Int J Clin Oncol; 2019 Dec; 24(12):1549-1557. PubMed ID: 31452019
[TBL] [Abstract][Full Text] [Related]
5. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
Ou SH; Zell JA
J Thorac Oncol; 2008 Mar; 3(3):216-27. PubMed ID: 18317063
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer.
Tufman A; Kahnert K; Kauffmann-Guerrero D; Manapov F; Milger K; Müller-Lisse U; Winter H; Huber RM; Schneider C
Strahlenther Onkol; 2017 May; 193(5):392-401. PubMed ID: 28246699
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of M descriptors of the 8th edition of TNM classification of lung cancer.
Dias M; Antunes A; Campainha S; Conde S; Barroso A
J Thorac Dis; 2017 Mar; 9(3):685-691. PubMed ID: 28449476
[TBL] [Abstract][Full Text] [Related]
8. The TNM 8 M1b and M1c classification for non-small cell lung cancer in a cohort of patients with brain metastases.
Nieder C; Hintz M; Oehlke O; Bilger A; Grosu AL
Clin Transl Oncol; 2017 Sep; 19(9):1141-1146. PubMed ID: 28357633
[TBL] [Abstract][Full Text] [Related]
9. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.
Eberhardt WE; Mitchell A; Crowley J; Kondo H; Kim YT; Turrisi A; Goldstraw P; Rami-Porta R;
J Thorac Oncol; 2015 Nov; 10(11):1515-22. PubMed ID: 26536193
[TBL] [Abstract][Full Text] [Related]
10. The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer.
Fong KM; Rosenthal A; Giroux DJ; Nishimura KK; Erasmus J; Lievens Y; Marino M; Marom EM; Putora PM; Singh N; Suárez F; Rami-Porta R; Detterbeck F; Eberhardt WEE; Asamura H;
J Thorac Oncol; 2024 May; 19(5):786-802. PubMed ID: 38320664
[TBL] [Abstract][Full Text] [Related]
11. Staging Lung Cancer: Metastasis.
Shroff GS; Viswanathan C; Carter BW; Benveniste MF; Truong MT; Sabloff BS
Radiol Clin North Am; 2018 May; 56(3):411-418. PubMed ID: 29622076
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of tumor size eliminating the ground glass opacity component: modified clinical T descriptors of the tumor, node, metastasis classification of lung cancer.
Nakamura S; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ishiguro F; Hirakawa A; Yokoi K
J Thorac Oncol; 2013 Dec; 8(12):1551-7. PubMed ID: 24389437
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
He YY; Zhang XC; Yang JJ; Niu FY; Zeng Z; Yan HH; Xu CR; Guan JL; Zhong WZ; Yang LL; Guo LH; Wu YL
Clin Lung Cancer; 2014 Nov; 15(6):441-7. PubMed ID: 25044104
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Rami-Porta R; Asamura H; Travis WD; Rusch VW
CA Cancer J Clin; 2017 Mar; 67(2):138-155. PubMed ID: 28140453
[TBL] [Abstract][Full Text] [Related]
17. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry.
Metzenmacher M; Griesinger F; Hummel HD; Elender C; Schäfer H; de Wit M; Kaiser U; Kern J; Jänicke M; Spring L; Zacharias S; Kaiser-Osterhues A; Groth A; Hipper A; Zaun G; Dörfel S; Güldenzoph B; Müller L; Uhlig J; Thomas M; Sebastian M; Eberhardt WEE;
Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36180086
[TBL] [Abstract][Full Text] [Related]
19. Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitors.
Liu S; Zhou F; Liu Z; Xiong A; Jia Y; Zhao S; Zhao C; Li X; Jiang T; Han R; Qiao M; Liu Y; He Y; Li J; Li W; Gao G; Ren S; Su C; Zhou C
Transl Lung Cancer Res; 2020 Aug; 9(4):1053-1066. PubMed ID: 32953484
[TBL] [Abstract][Full Text] [Related]
20. Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?
Wei S; Asamura H; Kawachi R; Sakurai H; Watanabe S
J Thorac Oncol; 2011 Feb; 6(2):310-8. PubMed ID: 21206387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
